Investigation of Red Cell Antiobody Screening Tests Gyeonggi Areas
´ëÇÑÀÓ»ó°Ë»ç°úÇÐȸÁö 2016³â 48±Ç 1È£ p.36 ~ p.40
(Kim Dai-Joong) - Bundang Jesaeng Hospital Department of Laboratory Medicine
¼ºÇöÈ£(Sung Hyun-Ho) - Dongnam Health University Department of Clinical Laboratory Science
¹ÚâÀº(Park Chang-Eun) - Namseoul University Molecular Diagnostics Research Institute Department of Biomedical Laboratory Science
Abstract
ÀûÇ÷±¸ µ¿Á¾¸é¿ªÀº ¼öÇ÷ÀÚ¿Í °ø¿©ÀÚ°£ÀÇ ÀûÇ÷±¸ Ç׿øÀÇ Â÷ÀÌÀÌ´Ù. ¼öÇ÷À» À§Çؼ´Â Ç÷±¸Çü°ú Ç÷ûÇüÀÌ ÀÏÄ¡ÇÏÁö ¾ÊÀ¸¸é ÀûÇ÷±¸ Ç×ü ¼±º° °Ë»ç°¡ ÇÊ¿äÇÏ¸ç ºÒÀÏÄ¡ÀÇ ¿øÀÎÀ» ÇظíÇÏ´Â °ÍÀÌ ÇʼöÀûÀÌ´Ù. ÀûÇ÷±¸ Ç×ü ¼±º°°Ë»ç´Â ÀÓ»óÀûÀ¸·Î À¯ÀÇÇÑ Ç×ü¸¦ °ËÃâÇÏ°í, ½Å¼Ó Á¤È®Çϸç, ½Å·ÚÇÒ ¼ö ÀÖ´Â ¹æ¹ýÀ¸·Î ¼öÇ÷¿¡ ¾Õ¼ ¿ì¼±ÀûÀ¸·Î ÇÏ´Â °ÍÀ» ±ÇÀåÇÑ´Ù. º» ¿¬±¸ÀÚµéÀº ´Ùºóµµ·Î °ËÃâµÈ E, D, M, E+c, C+e Ç×ü¿¡ ´ëÇÑ ¼±º°°Ë»ç¸¦ º¸°íÇÏ¿´´Ù. µû¶ó¼ ÀÌ·¯ÇÑ °á°ú·Î Ç×-D, Ç×-EÀÇ Ç×ü°¡ ½Å»ý¾Æ ¿ëÇ÷¼º Áúȯ, Áö¿¬Çü ¿ëÇ÷¼º ¼öÇ÷ºÎÀÛ¿ë ¹ÝÀÀÀÇ À§Çè¿äÀÎÀ¸·Î ÀνÄÇÏ°íÀÚ ÇÑ´Ù. ¶ÇÇÑ Ç÷¾×¾ÈÀü°ü¸®¸¦ Àû¿ëÇϱâ À§ÇØ ÀûÇÕÇÑ Ç×ü¼±º°°Ë»ç°¡ ¿ä±¸µÇ°í, ¼öÇ÷ À§Çè¿äÀÎÀÇ ¼±º°¿¡ ÀÖ¾î ´õ ³ªÀº È¿À²¼ºÀ» Á¦°øÇÒ °ÍÀ̸ç ÇâÈÄ¿¡ °¢ ±¹°¡¿¡ µû¶ó ½ÇÁúÀûÀÎ °ËÃâºóµµ¸¦ ã´Â ¿¬±¸°¡ ÇÊ¿äÇÒ °ÍÀ¸·Î »ç·áµÈ´Ù.
Red blood cell (RBC) alloimmunization results from genetic disparity of RBC antigens between donor and recipients. The discrepancy of RBC antibody screening test occurs when the results of red cell tests do not agree with those of the serum test. In order to select the proper blood units for transfusion, clarification of the cause of discrepancies is essential. The RBC antibody screening test is an easy, quick, and reliable method for detection of clinically significant antibodies. Antibody screening and identification is recommended prior to transfusion to determine whether there is blood group incompatibility. We reported that phenotyping for E, D, M, E+c, and C+e antibody screening test should be extended. Therefore, these results indicate that anti-D and anti-E alloantibodies were major risk factors for haemolytic disease of the newborn or delayed haemolytic transfusion reactions in this study population. We suggested that its antibody screening be adapted to blood safety interventions. Targeted screening of selected recipients at risk offers less value than universal antibody screening, and more research is needed to determine the real incidence of this national condition.
Å°¿öµå
Alloimmunization, Red blood cell antibody screening test, Transfusion
KMID :
1101420160480010036
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)
In this study, a single alloantibody was found most frequently. This study suggested its antibody screening be adapted to blood safety interventions.